biote Future Growth
Future criteria checks 4/6
biote is forecast to grow earnings and revenue by 49.4% and 14.5% per annum respectively while EPS is expected to grow by 52.2% per annum.
Key information
49.4%
Earnings growth rate
52.2%
EPS growth rate
Pharmaceuticals earnings growth | 21.8% |
Revenue growth rate | 14.5% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 05 Apr 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 279 | 23 | 36 | 46 | 2 |
12/31/2025 | 234 | 27 | 42 | 45 | 5 |
12/31/2024 | 202 | 20 | 32 | 29 | 5 |
12/31/2023 | 185 | 3 | 24 | 27 | N/A |
9/30/2023 | 184 | -3 | 24 | 26 | N/A |
6/30/2023 | 181 | -10 | 30 | 32 | N/A |
3/31/2023 | 173 | -17 | -5 | -3 | N/A |
12/31/2022 | 165 | -1 | -11 | -9 | N/A |
9/30/2022 | 158 | 3 | -8 | -5 | N/A |
6/30/2022 | 152 | 11 | -9 | -5 | N/A |
3/31/2022 | 145 | 24 | 29 | 33 | N/A |
12/31/2021 | 139 | 33 | 30 | 34 | N/A |
9/30/2021 | 133 | 37 | 28 | 31 | N/A |
12/31/2020 | 117 | 29 | 25 | 26 | N/A |
12/31/2019 | 110 | 21 | 24 | 25 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BTMD's forecast earnings growth (49.4% per year) is above the savings rate (2.3%).
Earnings vs Market: BTMD's earnings (49.4% per year) are forecast to grow faster than the US market (14.6% per year).
High Growth Earnings: BTMD's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: BTMD's revenue (14.5% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: BTMD's revenue (14.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BTMD's Return on Equity is forecast to be high in 3 years time